🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We're seeking outstanding applicants for two postdoc positions in my lab - one focused on immunology (buff.ly/3D5aElv) and the other focused on Intestine Chips (buff.ly/3ZJ5d4n). Spread the word and apply today! #PostdocPosition #PostdoctoralFellow #Hiring

In the face of adversity, we at the Wyss Institute won't stop pursuing our mission. We'll support our community, which has devoted itself to saving the lives of others & the planet. To do that, we need your help. Take a stand & show that science matters. wyss.harvard.edu/news/the-impor…

"This cautionary tale tells us much about how political interference and battles over ideology can stifle scientific advances, which are essential to improve the care of our patients." Don Ingber medpagetoday.com/opinion/second… MedPage Today Wyss Institute #MedTwitter #Harvard

Political interference & battles over ideology shouldn't stifle science. If you care for patients, join the fight to retain academic freedom, speak out to protect science, & ensure our ability to innovate based on facts. Read my op-ed in MedPage Today. medpagetoday.com/opinion/second…

Last week, at least one scientific journal received a letter from a top U.S. attorney asking it to respond to alleged bias. Now, NEJM has received a similar inquiry as… trib.al/qY1xjjf

When women spend 25% more time in poor health than men, the news that the government is slashing funding to the pivotal Women's Health Initiative highlights the importance of supporting & talking about women's health. Read more from STAT: bit.ly/448WOtF

For anyone who cares about their neighbors & the health of their loved ones, let's fight again for freedom. Now, it's not about taxation without representation; it's about science funding cessation without justification. If this resonates, please share. wyss.harvard.edu/news/common-se…

The NIH is adopting an initiative to expand human-based models like Organ Chips. This tech, commercialized by Emulate, Inc., enables faster, better, & cheaper drug development. We'll see more successful clinical trials & better treatments. nih.gov/news-events/ne…

When Ailsa Chang from NPR interviewed me, she asked how I felt receiving the stop work orders. I was surprised and incredibly frustrated, but I remain proud to be a Harvard faculty member because we must speak truth to power. Listen here: npr.org/2025/04/17/nx-…

Why should you care if scientific funding shrinks & academic institutions are under attack? University research drives innovation, job creation, & economic growth. Cuts threaten America's technological & economic leadership. Read more and share: bizjournals.com/boston/news/20…

I spoke with Roland Pease on the BBC's Science in Action about the timeline for scientific innovation, the valuable partnership between the U.S. Federal Government & universities, & the economic, intellectual, & medical impacts of recent funding freezes. bbc.in/3GKetyc

Boston’s high concentration of top universities, world-class hospitals, and venture capital firms makes it a perfect ecosystem for biotech innovation, but it's also left us vulnerable to the impact of political decisions. Read more from The Economist. economist.com/united-states/…

Whether it’s due to concerns for animal welfare or a desire for more successful clinical trials, more people are recognizing the importance of finding more accurate alternatives to animal models, like Organ Chips. Read more from Bloomberg. bloom.bg/43AXZ32

I’m so excited to announce the publication of this important paper in BMC showing the value of Organ Chips for personalized medicine and clinical care in esophageal adenocarcinoma. …nslational-medicine.biomedcentral.com/articles/10.11…

The Trump administration has launched a Blitzkrieg on science and academic freedom. As researchers, we must use our voices to advocate for science to protect patients, the economy, and truth itself. Read more in my op-ed in The Scientist. the-scientist.com/from-the-front…

Is animal testing becoming obsolete? Not yet, but on yesterday’s episode of On Point, I spoke with Meghna Chakrabarti about it's used in drug development and how Organ Chips, organoids, and AI, might be used to enhance, and one day replace, these methods. wbur.org/onpoint/2025/0…

15% of the drugs in the US’s development pipeline were made by companies headquartered in MA, which wouldn't be possible w/o government investments. Funding cuts leave this ecosystem at risk. Learn more in The Boston Globe. bostonglobe.com/2025/06/08/opi…

New paper out, amazing team Wyss Institute - Don Ingber Megan Sperry Anish Vasan and many others nature.com/articles/s4385… "AI-enabled drug prediction and gene network analysis reveal therapeutic use of vorinostat for Rett Syndrome in preclinical models"

So excited to see this paper on the stromal changes driving Barrett’s Esophagus progression to Cancer. A Herculean effort effort integrating scRNASeq/CODEX/ECM proteomics. Concerted changes in Epithelium and Stroma: a multi-scale, multi-omics... sciencedirect.com/science/articl…

Our work on the progression of Barrett’s esophagus into adenocarcinoma was published in Developmental Cell. Our findings suggest the need for treatment paradigms that go beyond targeting cancerous cells to incorporate stromal reprogramming. bit.ly/41djerh